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A Model for the Topology of Excitatory Amino
Acid Transporters Determined by the Extracellular
Accessibility of Substituted Cysteines
intracellular (Grunewald and Kanner, 1995; Wahle and
Stoffel, 1996). Residues comprising the first six hy-
drophobic stretches are conserved and are thought to
form a-helical transmembrane domains, based on hy-
dropathy analysis and on the results of a study demon-
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strating their ability to span the membrane (Wahle andPortland, Oregon 97201
Stoffel, 1996). Also, N-linked glycosylation of residues
in the loop between the third and fourth hydrophobic
domains indicates that this region resides extracellularlySummary
(Conradt et al., 1995).
A region near the C-terminal end of the EAATs (resi-Excitatory amino acid transporters (EAATs) function
dues 354±498 in EAAT1) shows unusually high sequenceas both substrate transporters and ligand-gated anion
conservation and has been implicated in substrate, in-channels. Characterization of the transporter's gen-
hibitor, and ion interactions, based on studies of chime-eral topology is the first requisite step in defining the
ras (Vandenberg et al., 1995; Mitrovic et al., 1998), site-structural bases for these distinct activities. While the
directed mutants (Pines et al., 1995; Kavanaugh et al.,first six hydrophobic domains can be readily modeled
1997; Zhang et al., 1998; Zhang and Kanner, 1999), andas conventional transmembrane segments, the orga-
substituted cysteine accessibilities (Seal and Amara,nization of the C-terminal hydrophobic domains, which
1998; Zarbiv et al., 1998). However, unlike the first sixhave been implicated in both substrate and ion interac-
domains, hydropathy analysis does not clearly delineatetions, has been controversial. Here, we report the re-
the number and orientation of transmembrane segmentssults of a comprehensive evaluation of the C-terminal
formed by this region. Furthermore, studies to examinetopology of EAAT1 determined by the chemical modifi-
their topology have not yet resolved this ambiguity. In-cation of introduced cysteine residues. Our data sup-
vestigations of GLAST1, the rat homolog of EAAT1port a model in which two membrane-spanning do-
(Wahle and Stoffel, 1996), GltT, a glutamate transportermains flank a central region that is highly accessible
from B. stearothermophilus (Slotboom et al., 1996), andto the extracellular milieu and contains at least one
DctA, a dicarboxylic transporter from R. melioti (Jordingreentrant loop domain.
and Puhler, 1993), employed strategies to assess the
membrane orientation of a reporter epitope fused toIntroduction
sequential C-terminal deletions of the transporter. De-
spite the use of similar strategies, different models of
In the nervous system, excitatory amino acid transport-
the C-terminal domains were proposed: four b strands
ers (EAATs) can serve a dual function as transporters (GLAST1), four a helices (GltT), or six a helices (DctA).
that regulate extracellular glutamate levels (Mennerick Moreover, because these studies analyzed truncated,
and Zorumski, 1994; Tong and Jahr, 1994; Otis et al., and therefore nonfunctional, carriers their structures
1996; Diamond and Jahr, 1997) and as ligand-gated may not reflect the structure of the native carriers. A
anion channels that can modulate cellular excitability model for the topology of GLT-1, the rat homolog of
(Eliasof and Werblin, 1993; Fairman et al., 1995; Picaud human EAAT2, has been proposed based on experi-
et al., 1995; Wadiche et al., 1995; Gaal et al., 1998). The ments using thiol modification of cysteine substitution
observation of both channel and carrier functions within mutants expressed in HeLa cells (Grunewald et al.,
a single family suggests that EAATs may have structural 1998). Recently, we reported the results of experiments
motifs in common with ion channels and ion-coupled exploring the functional role of 24 consecutive residues
transporters (DeFelice and Blakely, 1996; Sonders and (P392±Q415) in a highly conserved C-terminal domain
Amara, 1996; Seal and Amara, 1999). Initial insight into of EAAT1 (Seal and Amara, 1998). In this study, we exam-
the structure of this transporter family came from the ined the effect of thiol modification on the substrate
isolation of genes that encode both eukaryotic GLAST1 transport and inhibitor binding by cysteine substitution
(Storck et al., 1992), GLT-1 (Pines et al., 1992), EAAC1 mutants in this region and proposed that the domain
(Kanai and Hediger, 1992), EAAT4 (Fairman et al., 1995), forms a reentrant loop similar to those found in ion chan-
and EAAT5 (Arriza et al., 1997) and prokaryotic DctA nels. The orientation of this reentrant loop, predicted
(Engelke et al., 1989), GltP (Tolner et al., 1992a), and from the analyses of function, contradicted several as-
GltT (Tolner et al., 1992b) members. High amino acid pects of previous models (i.e., Grunewald et al., 1998)
conservation of the mammalian subtypes with each and thus provided the rationale for a more extensive
other (50%±60%) and with the bacterial subtypes (30%± reevaluation of the topology of the entire C-terminal
40%) suggests that they share a similar overall structure. region.
A comparison of the five mammalian subtypes shows To gain a more comprehensive understanding of the
a lack of conservation between residues at their N- and topology of the C-terminal half of the human EAAT1
C-terminal ends, domains that have been identified as transporter, we have analyzed the accessibility of indi-
vidual cysteines, substituted for over one hundred indi-
vidual residues throughout this region (residues 307±³ To whom correspondence should be addressed (e-mail: amaras@
ohsu.edu). 527), to sulfhydryl-modifying reagents that vary in size,
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Figure 1. Hydropathy Analysis of EAAT1 and
Assignment of Putative Domains
(A) Sequence of amino acid residues in the
C-terminal half of EAAT1, beginning with the
extracellular loop after transmembrane do-
main 5 (TM 5) (V302) and ending with the last
residue of the carrier (M543). Domains 6±11,
derived from hydropathy analyses and amino
acid conservation, are indicated by bars
drawn over the residues that comprise them.
(B) Hydropathy plot of EAAT1 generated by
the method of Kyte-Doolittle, with a window
size of 10. Six regions within the first z350
amino acid residues score strongly as hy-
drophobic (domains 1±6), and five regions in
the final z200 residues appear to be only
moderately hydrophobic (domains 7±11).
charge, and membrane permeability. The extracellular The extracellular accessibility of the single cysteine
substitutions was evaluated by two related biochemicalaccessibility of cysteine residues in functional mutants
was evaluated biochemically by demonstrating that mem- assays (Loo and Clarke, 1995; Chen et al., 1998; Grune-
wald et al., 1998; Seal et al., 1998). In one assay, cellsbrane-impermeant, hydrophilic, thiol-reactive compounds
block the subsequent binding of their biotinylated deriv- expressing the mutant carriers were incubated in the
presence or absence of membrane-impermeant stilbeneatives in intact COS7 cells. In addition, a functional assay
was employed to demonstrate that the carriers were disulfonate maleimide (SM) or the membrane-imperme-
ant methanethiosulfonate (MTS) derivative (2-[trimethyl-modified when they were at the cell surface. We now
provide both biochemical and functional evidence to ammonium] ethyl) methanethiosulfonate (MTSET), fol-
lowed by incubation with the membrane-permeantsupport an alternative topology for several domains
within the last half of the EAA transporter molecule. biocytin maleimide (BM). Transporter mutants were im-
munoprecipitated using a polyclonal antibody raised to
the C-terminal 46 amino acid residues of EAAT1 (EliasofResults
et al., 1998) and then probed for the biotin moiety by
Western blotting with strepavidin conjugated to horse-As a means of reference, we have divided EAAT1 into
eleven discrete domains representing putative mem- radish peroxidase (HRP). Residues in which modifica-
tion could be blocked with SM score as extracellular.brane-spanning or membrane-associated regions (Fig-
ure 1A). Domain designations were given to stretches The presence of the transporter in each lane was con-
firmed by reprobing the blots with the EAAT1 antibody.of z16±25 residues that score as hydrophobic and that
show a high degree of conservation among the five In a second approach, MTS derivatives were used to
identify residues that are exposed to the extracellularcloned human subtypes (EAATs 1±5). Hydropathy analy-
sis (Kyte and Doolittle, 1982) predicts six strongly hy- side of the membrane. MTS derivatives react specifically
and rapidly with the sulfhydryl group of cysteine anddrophobic domains within the first z350 residues (do-
mains 1±6) and five moderately hydrophobic domains are a billion times more reactive in aqueous than in lipid
environments (Roberts et al., 1986; Karlin and Akabas,in the remaining portion (domains 7±11) (Figure 1B).
The topology of residues throughout the C-terminal 1998). Because the MTS derivatives are smaller than are
the maleimide derivatives, they have the advantage thatportion of the carrier (307±527) was investigated by indi-
vidually replacing them with cysteine and then examin- they may react with residues that are inaccessible to
the larger maleimides, including residues that reside ining their accessibility to thiol-reactive compounds. Sin-
gle cysteine substitutions were created in a functional, an aqueous crevice within the membrane. Cells express-
ing the mutant transporters were incubated in the pres-cysteineless version of EAAT1 (Cys[2]) that has been
characterized previously (Seal and Amara, 1998). The ence or absence of the charged, membrane-impermeant
MTS derivatives (2-sulfonatoethyl) methanethiosulfonateability of each mutant to accumulate radiolabeled L-gluta-
mate over background levels was measured and then (MTSES) and MTSET and then incubated with a neutral,
biotin-conjugated MTS derivative, N-biotinylaminoethylnormalized to the amount of transport by Cys(2) in the
same experiment (see Experimental Procedures). Table methanethiosulfonate (MTSEA-biotin). MTSES (negatively
charged) and MTSET (positively charged) were applied1 summarizes the results obtained on the function and
reactivities of the mutants generated in each domain. for 5 min at 10 mM and 1 mM, respectively. Based on
empirically determined reactivity rates of MTSES andUptake values are only reported for mutant carriers upon
which topological determinations were made and are MTSET with free sulfhydryls in solution (Stauffer and
Karlin, 1994) and with accessible thiols in a variety ofexpressed as a percent of the uptake of Cys(2) (Table
1; see below). membrane proteins, these concentrations should react
Topology of a Glutamate Transporter
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Table 1. Reactivity and Functional Properties of Single Cysteine Mutants
Uptake values are expressed as a percent of the Cys(-) velocity and are the mean 6 SD for n . 2 experiments performed in triplicate. Mutants
with uptake values ,10% are severely impaired (SI). A substitution was either reactive (closed circles), not reactive (open circles), or partially
reactive (half-closed circles) with the indicated reagent: biocytin maleimide (BM), MTSEA-biotin (MB), stilbene disulfonate malmeimide (SM),
MTSET (ET), or MTSES (ES).
to completion with any thiol group that has unrestricted preincubated with impermeant compounds, then the
membrane orientation of the residue cannot be deter-access to the extracellular milieu. Biotinylated proteins
were isolated by avidin-affinity chromatography and mined by this approach (see Table 1).
then probed by Western blot for the presence of the
biotin-isolated transporter using the C-terminal EAAT1 Membrane-Impermeant Compounds Do Not Block
Labeling of an Intracellular Residueantibody. In the case in which biotinylation of the trans-
porter is blocked by preincubation with the impermeant The sulfhydryl reagents that we used to identify residues
accessible from the extracellular milieu (MTSES,reagents, then the residue must be accessible to the
extracellular milieu. If the cysteine substitution does not MTSET, and SM) have been shown to be membrane
impermeant in various systems (Loo and Clarke, 1995;react appreciably with either BM or MTSEA-biotin or
if it fails to show a reduction in biotin labeling when Holmgren et al., 1996; Chen et al., 1998; Grunewald et
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protein in each lane (Figure 2A, lower panel). MTSES
(10 mM) and MTSET (1 mM) also appear unable to inhibit
BM labeling of the A527C transporter (Figure 2B). In
contrast, compounds known to be membrane permeant,
such as N-ethylmaleimide (NEM) (0.2 mM) and (2-ami-
noethyl) methanethiosulfonate (MTSEA) (concentrations
.0.5 mM) (Holmgren et al., 1996), readily blocked biotin
labeling (Figures 2C and 2D, upper panel). Again, the
transporter is present in each lane (Figures 2C and 2D,
lower panel). These results clearly demonstrate that in
our system, the membrane-impermeant compounds
MTSES, MTSET, and SM do not modify an intracellular
residue when applied to the extracellular side of intact
COS7 cells, whereas compounds that are known to per-
meate the membrane, NEM, MTSEA, and BM, readily
react with this residue. MTSEA-biotin is reported to be
relatively membrane impermeant in HEK293 cells (Chen
et al., 1998). Under the conditions used here, MTSEA-
biotin does not readily label A527C (Figure 4), and thus
it does not appear to cross the membrane to a significant
extent in this system either.
Extracellular Localization of Cysteine Substitutions
We began our evaluation of the number and orientation
of membrane-spanning domains in the C-terminal por-
tion of the carrier by determining the extracellular acces-
sibility of residues in a hydrophilic loop between hy-
drophobic domains 5 and 6. Two cysteine substitutions
in this loop, M307C and G308C, appear to react with
Figure 2. Membrane-Permeant but Not -Impermeant Reagents BM and can be blocked by preincubation with the imper-
Modify an Intracellular Residue of EAAT1, A527C, in Intact COS7 meant SM (Figure 3A) or MTSET (Figure 3B; data not
Cells
shown) compounds. Reprobing the blot with the EAAT1
(A) Cells expressing the A527C transporter were preincubated with
C-terminal antibody confirms that the transporter isor without 1 mM or 0.2 mM impermeant SM, followed by incubation
present in each lane (Figures 3A and 3B, lower panels).with 1 mM BM. The blot was probed with strepavidin-HRP to detect
MTSEA-biotin also labels these two cysteines, and thisbiotin labeling of the 66 kDa A527C transporter (upper panel) and
then reprobed with the C-terminal antibody to EAAT1 to show the reaction can be blocked by preincubation with the mem-
presence of the 66 kDa A527C transporter in each lane (lower panel). brane-impermeant MTSES and MTSET compounds
EAAT1 antibody IgGs are observable on both blots. (Figure 4). Thus, the cysteine residues substituted for
(B) Cells were preincubated with or without the membrane-imperme-
M307 and G308 are readily accessed from the extracel-ant compounds MTSET (1 mM) and MTSES (10 mM), followed by
lular milieu (Table 1).incubation with 1 mM BM. Blot was probed with strepavidin-HRP
There is a region of several consecutive serine/threo-(upper panel) and then reprobed with C-terminal antibody to EAAT1
(lower panel). nine residues (T362±S366) that appears by hydropathy
(C) Cells were preincubated with or without concentrations of the analysis to reside at the C-terminal end of the seventh
membrane-permeant MTSEA ranging from 0.1 to 2.5 mM and then hydrophobic domain (Figure 1). Two residues, S366C
incubated with 0.2 mM BM. Blot was probed with strepavidin-HRP
and A367C, label with both BM and MTSEA-biotin. SM(upper panel) and then reprobed with C-terminal antibody to EAAT1
(Figure 3A), MTSET (Figures 3B and 4), and MTSES (Fig-(lower panel).
ure 4) prevent subsequent labeling with the biotin-con-(D) Cells were incubated with or without 0.1 mM of the membrane-
permeant NEM and then incubated with 0.2 mM BM. Blot was taining compounds. Furthermore, as shown in Figure 5,
probed with strepavidin-HRP (upper panel) and then reprobed with the glutamate transport activity of these two mutants is
a C-terminal antibody to EAAT1 (lower panel). markedly inhibited after a 5 min exposure to either 10
mM MTSES or 1 mM MTSET. The reactivity rate of S366C
with MTSET and MTSES indicates that this cysteine isal., 1998). To establish that they do not permeate the
plasma membrane in our system, we tested whether highly accessible to the aqueous milieu (kMTSET < 4000
M21s21; kMTSES < 1000 M21s21; R. P. S., unpublished data).these reagents could react with a cysteine substituted
for a residue (A527) in the well-established intracellular These findings strongly suggest that the S366C and
A367C residues can be accessed from the extracellularC terminus of the transporter (Grunewald and Kanner,
1995; Wahle and Stoffel, 1996). As shown in the upper space in carriers expressed on the cell surface (Figure
6; Table 1).panel of Figure 2A, when cells expressing A527C are
preincubated with SM at concentrations of 0.2 mM or Two other residues in this region, T362C and S363C,
react with MTSEA-biotin but not with BM. Interestingly,1 mM, BM labeling of a 66 kDa transporter band is
detected to approximately the same extent as without while MTSES blocks modification by MTSEA-biotin at
these two residues, MTSET only partially blocks theSM pretreatment. Reprobing the blot with the EAAT1-
specific antibody shows the presence of the transporter reaction (Figure 4). Because both MTSEA-biotin and
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Figure 3. BM Labeling of Single Cysteine
Substitution Mutants Is Prevented by SM and
MTSET
(A) Cells expressing the cysteine substitution
mutants were preincubated with or without
the membrane-impermeant SM compound
for 30 min and then incubated with BM for
30 min. The concentrations of reagents used
with each mutant were 0.2 mM SM and 0.2
mM BM (M307C, S366C, and T462C), 1 mM
SM and 1 mM BM (A367C, A395C, F423C,
G442C, I453C, L467C, I468C, I469C, and
A470C), or 0.2 mM SM and 2 mM BM (G308C).
The blot was probed with strepavidin-HRP to
detect biotin labeling (upper panel) and then
reprobed with a C-terminal antibody to
EAAT1 (lower panel). This figure is a compos-
ite of representative experiments.
(B) Cells expressing the cysteine substitution
mutants were preincubated with or without
the impermeant MTSET compound at 1 mM
for 5 min and then incubated with BM for 30
min. Concentrations of the BM compound for
each mutant were 0.02 mM BM (S366C), 0.2
mM BM (T462C), or 1 mM BM (M307C, A367C,
A395C, F423C, G442C, I453C, L467C, and
I468C). The blot was probed with strepavidin-
HRP (upper panel). Blot was reprobed with a
C-terminal antibody to EAAT1 (lower panel).
This figure is a composite of representative
experiments.
MTSES were shown to be impermeant under these con- the modification of A414C by MTSEA of 104 6 15 M21
s21, suggesting that this residue is readily accessible toditions, the data further support the contention that this
region of EAAT1 is accessible to the extracellular space. an aqueous milieu (Seal and Amara, 1998). The labeling
pattern of F423C, a residue located in a hydrophilic, non-Also, the partial reactivity of MTSET suggests that a
positive electrostatic potential may be present along the conserved region of the carrier downstream of A414,
suggests that this region is also quite accessible and iswater-accessible pathway to these sulfhydryl groups.
In a recent study, we demonstrated that a cysteine likely to be outside. This substitution reacts with BM,
and both SM (Figure 3A) and MTSET (Figure 3B) blocksubstituted for one residue at each end of domain 8,
A395 and A414, could be modified with MTSES and this labeling. Similarly, MTSES and MTSET block label-
ing by MTSEA-biotin (Figure 4). The accessibility of thisMTSET and that a majority of the cysteines substituted
for residues in this domain were accessible to MTSEA substitution to an array of thiol-modifying reagents sup-
ports its placement in the extracellular milieu.(Seal and Amara, 1998). These results, together with
the results of mutagenesis studies (Pines et al., 1995; Following this loop is a span of z39 highly conserved
residues (G424±T462) that score strongly as two hy-Kavanaugh et al., 1997; Zhang et al., 1998), suggest the
formation of a reentrant loop by this domain (Seal and drophobic domains (9 and 10) (Figure 1B). Seven cys-
teine substitutions in domain 9 and four in domain 10Amara, 1998). Here, we demonstrate that the A395C and
A414C residues can also be readily labeled by MTSEA- are accessible to either MTSEA-biotin or BM. T428C,
located at the beginning of domain 9, can be labeledbiotin and that preincubation with MTSES and MTSET
can prevent this labeling (Figure 4). In addition, A395C with MTSEA-biotin, and this labeling can be blocked
by preincubation with MTSES and MTSET (Figure 4).also reacts with the larger BM compound, while SM
(Figure 3A) and MTSET (Figure 3B) block this modifica- Positioned just four residues away is another cysteine
substitution (T432C) that also labels with MTSEA-biotintion. Cysteines substituted at three other positions in
this domain (T396, Y405, and A410) readily react with but does not react with either MTSES or MTSET (Figure
4). MTSEA (2.5 mM), a membrane-permeant compoundMTSEA-biotin but do not appear to react with either
MTSES or MTSET (Figure 4). These findings are consis- that exists in both neutral and positively charged forms,
blocks labeling by MTSEA-biotin (data not shown). Thetent with earlier observations in which T396C, Y405C,
and A410C were accessible to MTSEA but not to the reactivity of T432C with MTSEA-biotin and MTSEA sug-
gests that it resides in an aqueous environment. Fivelarger, charged MTSES and MTSET compounds (Seal
and Amara, 1998). It may be that electrostatic interac- consecutive residues on the C-terminal side of this do-
main are also highly accessible to modification whentions prevent access of the charged reagents (MTSET
and MTSES) to these cysteine residues. Nevertheless, substituted with cysteine. I438C and G439C behave sim-
ilarly to one another in that MTSEA-biotin labeling canthe results presented here add support to the contention
that domain 8 forms a reentrant membrane loop (Figure be completely blocked by MTSES but only partially
blocked by MTSET (Figure 4). This unusual accessibility6; see Discussion).
In a previous study, we observed a reaction rate for pattern is similar to what is observed with T362C and
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Figure 4. MTSEA-Biotin Labeling of Cysteine
Substitutions Is Prevented by MTSES and
MTSET
Cells expressing the cysteine substitution
mutants were preincubated with membrane-
impermeant MTS derivatives, 1 mM MTSET
or 10 mM MTSES, for 5 min at room tempera-
ture and then incubated with 2 mM MTSEA-
biotin for 30 min. Blots were probed with a
C-terminal antibody to EAAT1. This figure is
a composite of representative experiments.
S363C. The following two residues, A440C and A441C, while substitutions located throughout domain 10 ap-
pear to be accessible.are also accessible to modification by MTSEA-biotin,
and this can be blocked by preincubation with either Four consecutive residues following domain 10 (L467±
A470) also appear to be highly accessible to the thiol-MTSES or MTSET (Figure 4). Finally, G442C, located at
the end of domain 9, is accessible to all of the reagents modifying reagents when substituted to cysteine. Each
mutant can be labeled with either BM (Figures 3A andtested (Figures 3A, 3B, and 4; Table 1).
Two cysteine substitutions in domain 10 (I453C and 3B) or MTSEA-biotin (Figure 4), and these reactions can
be blocked with SM (Figure 3A), MTSES (Figure 4), andT462C) show reactivity with the entire array of thiol-
reactive reagents (Table 1). The reactivity of these resi- MTSET (Figures 3B and 4). Two other substitutions made
in this hydrophilic region of the carrier (W473C anddues with BM can be blocked by preincubation with SM
(Figure 3A) and MTSET (Figure 3B), and their reactivity F474C) react with both MTSET and MTSES to prevent
MTSEA-biotin from labeling (Figure 4). The high accessi-with MTSEA-biotin can be blocked by both MTSET and
MTSES (Figure 4). Two more substitutions (V452C and bility of cysteines substituted for residues L467 through
A470 clearly establishes this region as extracellular,V458C) are reactive with MTSEA-biotin but not BM (Ta-
ble 1). MTSEA-biotin labeling of these residues is pre- while the less accessible W473C and F474C residues
could either be in the extracellular space or in an aque-vented by MTSES and MTSET (Figure 4). Thus, substitu-
tions made at both ends of domain 9 appear to be highly ous pocket within the plane of the lipid bilayer.
Domain 11 (zL475±E495) is another highly conservedaccessible to modification by impermeant reagents,
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outside of the cell because, both in our study and the
work of others, MTSEA-biotin generally behaves as if it
is membrane impermeable (Chen et al., 1998; Boileau
et al., 1999). Our topological model of the carrier, illus-
trated in Figure 6, is based on data that fulfill the more
stringent criteria for extracellular accessibility, in which
modification by biotin-conjugated compounds can be
blocked by the well-established impermeant reagents
SM, MTSES, and/or MTSET.
Biochemical and Functional Evidence Indicates
that Domain 7 Spans the Membrane andFigure 5. Transport Activity of S366C and A367C Carriers Is Abol-
ished by MTSES and MTSET Domain 8 Forms a Reentrant Loop
Our results resolve the orientation of several domainsCells expressing the S366C and A367C transporters were incubated
in the presence or absence of either 10 mM MTSES or 1 mM MTSET that previously had not been directly examined. For ex-
for 5 min at room temperature. Radiolabeled L-glutamate uptake ample, two highly reactive substitutions (S366C and
was measured and plotted as the PI of uptake. Data are expressed A367C) made at the C-terminal end of domain 7 react
as the mean 6 SD of two to three independent experiments.
with all five of the sulfhydryl reagents tested (Table 1),
including the impermeant MTS derivatives and the larger
maleimide derivatives, indicating that this region of thedomain in the carrier that contains several polar and
charged residues and is thus somewhat hydrophilic (Fig- carrier is extracellular (Figure 6). Moreover, the dramatic
decrease in transport activity observed with these carri-ures 1A and 1B). Previous studies have shown that the
individual mutation of residues in and around this region, ers after exposure to MTSES and MTSET clearly estab-
lishes that the residues are modified when the transport-D470 in GLT-1 (Pines et al., 1995) and R479 in GLAST1
(Conradt and Stoffel, 1995), abolishes transporter func- ers are at the plasma membrane (Figure 5). We have
modeled domain 7 as an a helix to be consistent withtion. We observed MTSEA-biotin reactivity with only one
of the cysteine substitutions created in this domain, the a-helical structures predicted for the six membrane-
spanning domains that precede it. Alternatively, theR477C (Figure 4). The impermeant reagents MTSES or
MTSET do not prevent subsequent labeling of this resi- number of residues available to span the membrane
(z15±17) appears to be slightly less than the z20 resi-due by MTSEA-biotin (Figure 4), although the mem-
brane-permeant MTSEA does (data not shown). These dues typically required for a membrane-spanning a he-
lix, and thus it is conceivable that it crosses the mem-findings demonstrate that R477C faces an aqueous en-
vironment and suggests that it may be accessed only by brane as a more extended structure (i.e., a b strand)
(Wahle and Stoffel, 1996).uncharged reagents. Electrostatic interactions between
the carrier and the charged MTS derivatives would likely A reentrant loop structure for domain 8 is suggested
by the reactivity of single cysteine substitutions locatedunderlie this selectivity.
at both ends of this region (Figure 6; Table 1). We pre-
viously demonstrated that cysteines substituted for oneDiscussion
residue at each end of the domain (A395C and A414C)
react with MTSES and MTSET to abolish the transportBy examining the reactivity of cysteine substitutions
with thiol-specific reagents that differ with respect to activity of these mutant carriers (Seal and Amara, 1998).
Here, we provide biochemical evidence that furthersize, charge, and membrane permeability, we have de-
termined the extracellular accessibility of residues demonstrates the extracellular accessibility of both the
A395C and A414C residues, as well as residues thatthroughout the C-terminal half of the EAAT1 transporter.
In functional, surface-expressed mutants, three different both precede (S366C and A367C) and directly follow
(F423) this region (Figure 6; Table 1).patterns of reactivity were observed with the thiol-spe-
cific reagents. First, there are residues that react with Several lines of evidence provided by mutagenesis-
(Pines et al., 1995; Kavanaugh et al., 1997; Zhang et al.,both the large maleimide derivatives (BM and SM) and
the smaller MTS derivatives (MTSEA-biotin, MTSES, and 1998), chimera- (Vandenberg et al., 1995; Mitrovic et al.,
1998), and substituted cysteine accessibility± (Seal andMTSET) and thus are modeled as residing in the extra-
cellular space. Second, a subset of residues react with Amara, 1998; Zarbiv et al., 1998) based studies indicate
that this domain participates in the formation of a sub-the MTS derivatives but not with BM. These residues
are also on the water-accessible surface of the protein strate translocation pathway. For example, substrates
and competitive inhibitors protect a cysteine substitutedand are readily accessible from the extracellular space.
However, because of the small size of the MTS com- for a residue in domain 8 (A395 in EAAT1) from modifica-
tion by MTSES or MTSET (Seal and Amara, 1998). Twopounds, they could reside either extracellularly or in an
aqueous crevice or pore within the plane of the lipid residues located in the center of this domain (Y405 and
E406 in EAAT1 and Y403; E404 in GLT-1) have beenbilayer. A third class of residues appear to react only
with MTSEA-biotin and MTSEA. Possible electrostatic implicated in cotransported ion interactions (Seal and
Amara, 1998; Zarbiv et al., 1998), and Y403 appears tointeractions between MTSES or MTSET and the carrier
may limit the access of these charged reagents to the be alternately exposed to either side of the membrane,
depending on whether substrates or inhibitors are pres-cysteine substitutions. Despite their more limited reac-
tivity, these residues are likely to be accessed from ent (Zarbiv et al., 1998). Also, most of the side chains
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Figure 6. Schematic Representation of EAAT1 Topology
The topological model of EAAT1, based on the extracellular accessibility of cysteine substitutions. Residues labeled red represent substitutions
that are accessible to all of the thiol-reactive reagents and thus reside in the extracellular space. Residues labeled yellow represent those
that react with MTSEA-biotin and MTSET and/or MTSES and therefore are accessible to the extracellular space. Residues labeled blue are
substitutions that are only accessible to MTSEA-biotin and MTSEA and thus face an aqueous milieu. A527C (green) only reacts with membrane-
permeant reagents (BM, NEM, and MTSEA). Hydrophobic domains 1±7 and 11 are modeled as transmembrane a helices, while domain 8 is
modeled as a reentrant loop. Many substitutions within domains 9 and 10 react with the impermeant reagents and thus are modeled as closely
associated with the extracellular space. No secondary structure predictions are made for domains 8±10. Positively and negatively charged
residues of the carrier are indicated by plus and minus signs, respectively.
of the residues that comprise domain 8 face an aqueous that the intracellular placement of residues in the GLT-1
model is based on their ability to be modified with BM inmilieu (Seal and Amara, 1998). A water-accessible reen-
trant membrane loop comprised of residues that interact cells permeabilized with streptolysin O. With membrane
permeabilization, the predominant sites that are labeledwith substrates and cotransported ions from both sides
of the membrane is congruent with current models of correspond to immature forms of carriers present in
internal membrane compartments and not to the func-the transport mechanism (Lester et al., 1994; DeFelice
and Blakely, 1996; Sonders and Amara, 1996). Together, tional carriers at the plasma membrane. Biogenesis
studies of two highly homologous water channels,these findings support the contention that this domain
of the carrier forms part of a pore for the translocation CHIP28 and MIWC, indicate that their transmembrane
topologies differ in the endoplasmic reticulum but thatof substrates and cotransported ions similar to those
found in many ligand- and voltage-gated channels (re- they share a similar structure at the plasma membrane
(Shi et al., 1995). Similarly, the EAA transporters mayviewed by MacKinnon, 1995).
In a recent report, the topology of the GLT-1 trans- undergo topological transitions as they traffic through
intracellular compartments to the plasma membrane.porter (the rat homolog of EAAT2) was evaluated using
thiol-specific modifying reagents to determine the mem- Thus, experiments that assess the orientation of imma-
ture, intracellular forms of the carrier may not necessarilybrane orientation of individual cysteine substitutions
(Grunewald et al., 1998). The results of this study were provide an accurate assessment of the conformation of
the mature, active, surface-expressed transporters.the basis for a model with seven a-helical transmem-
brane domains followed by three shorter membrane-
associated segments, and ending with an eighth a-heli- Residues at Both Ends of Domains 9 and 10 Are
Accessible to the Extracellular Spacecal transmembrane domain. This model interprets our
membrane-spanning domain 7 as an intracellular loop The observation that residues at both the N- and C-ter-
minal ends of domains 9 and 10 react with membrane-and our proposed P loop as a membrane-spanning a helix
oriented from inside to outside. Although it is formally impermeant reagents suggests that the ends of each
domain are exposed to the extracellular milieu. Thesepossible that the two different members of the family,
EAAT1 and GLT-1, have different topologies, there are a findings argue against a previously proposed topology
in which domains 9 and 10 span the membrane as anumber of differences in the experimental approaches that
could account for the discrepancies between the two helices oriented from extracellular to intracellular (do-
main 9) and intracellular to extracellular (domain 10)interpretations of the model. A significant difference is
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(Slotboom et al., 1996). The extracellular accessibility orientation. For example, previous studies have demon-
pattern of residues in domain 9 is such that residues strated that domain 6, which scores strongly as hy-
positioned at the ends of the domain are the most acces- drophobic, has the capacity to span the membrane
sible (F423C±T432C, I438C±G442C), and residues in the (Wahle and Stoffel, 1996). Thus, although none of substi-
center are the least accessible (A433C±A436C) (Figure tutions made in the hydrophilic loop following domain
6). In addition to the substitutions found at the ends of 6 were accessible, we propose that this loop resides
domain 10 (G442 and V458), two substitutions located intracellularly (Figure 6). Similarly, the region between
near its center are also highly accessible (V452C and A367 (C-terminal end of domain 7) and A395 (N-terminal
I453C). Based on these results, it appears that domains end of domain 8) could not be accessed by the cysteine-
9 and 10 are more likely to be closely associated with specific biotin-containing derivatives in this study or
the extracellular milieu than to interact exclusively with by trypsin proteolysis in previous studies of the GLT-1
lipids. transporter (Grunewald and Kanner, 1995; Grunewald
et al., 1998). Based on the extracellular location deter-
Extracellular Accessibility of Several Residues mined for A367C and A395C and on the fact that many
Contributes to Defining the Last of the residues that comprise this region are extremely
Transmembrane Domain hydrophilic (z25% of residues are charged) (see Figures
Identification of the final membrane-spanning segment 1A and 6), it seems unlikely that this region resides in
was facilitated by the reactivity of residues that precede
the intracellular milieu or that it interacts with lipids. For
the last conserved domain of the carrier (domain 11)
these reasons, we favor a model in which these residues
(see Figures 1A and 6). The region spanning from L467
are closely associated with the extracellular space (seeto F474 is one of the most highly accessible regions of
Figure 6).the transporter. Four consecutive residues in this region,
when substituted to cysteine, are accessible to all of
the thiol-modifying reagents (L467C±A470C), clearly es-
Implications for Overall Structuretablishing that they reside in the extracellular space (Fig-
The reactivity at residues in each of the C-terminal do-ure 6; Table 1). The other two substitutions made in this
mains (7±10) of EAAT1 indicates their accessibility to anregion (W473C and F474C) react with MTSEA-biotin,
aqueous environment and their close association withMTSES, and MTSET (Figure 4) and thus may reside either
the extracellular milieu. In theory, the secondary struc-in the extracellular space or in an aqueous crevice within
ture of a region can be inferred from the accessibilitythe membrane. We have modeled the last transmem-
of its residues to thiol modification (Akabas et al., 1994;brane as spanning from zL475 to V494 (domain 11)
Javitch et al., 1995). Although we observed reactivity atbecause our data indicate that its N-terminal end begins
several residues within a domain, no definitive second-at or after V471 and because both the moderate hydro-
ary structure patterns emerged. As described pre-phobicity and the high amino acid conservation end
viously, this part of the carrier is clearly involved in sub-at zV494. Topological models proposed for both GltT
strate recognition and cotransported ion interactions(Slotboom et al., 1996) and GLT-1 (Grunewald et al.,
(Vandenberg et al., 1995; Kavanaugh et al., 1997; Zhang1998) describe the region from zA470 to zL489 as the
last transmembrane configured as an amphipathic a et al., 1998; Mitrovic et al., 1998; Seal et al., 1998; Zarbiv
helix, with one side of the helix proposed to face an et al., 1998; Zhang and Kanner, 1999) and thus is likely
aqueous compartment. A short b-stranded transmem- to form structures that facilitate their recognition and/
brane segment comprised of only a subset of the resi- or translocation. For example, some of these C-terminal
dues in this region (Wahle and Stoffel, 1996) would also domains may reside within the plane of the membrane
be consistent with our data. as short segments that form one or more pores for sub-
strate translocation and/or the flux of uncoupled ions.
Modeling of Regions Inaccessible Alternatively, some of the domains may fold into a globu-
to Modifying Reagents lar structure that could participate in substrate binding
In some regions of the carrier, no substitutions were and ion access to the permeation pathway, similar to
accessible to modification by the biotin-conjugated re- what has been established for the extracellular ligand
agents. In using accessibility methods such as the ones binding domains of a rat ionotropic glutamate receptor
employed here, the membrane orientation of a residue (iGluR2) (Armstrong et al., 1998) and the metabotropic
or region can only be firmly established if it is accessible
glutamate receptors (O'Hara et al., 1993). In the absence
to membrane-impermeant reagents, such as sulfhydryl-
of a high-resolution image of the carrier, knowledge ofspecific compounds, antibodies, or proteolytic en-
the transporter's tertiary (ªdomain packingº) and quater-zymes. Residues or regions that are inaccessible may
nary (Haugeto et al., 1996) structures will likely be thebe so for a number of reasons. It may be that they are
next steps toward an understanding of the overall carriertoo closely associated with the lipid bilayer, are in a
structure. In the meantime, the results presented hereparticularly inaccessible secondary structure, are in-
provide direct evidence for the extracellular accessibilityvolved in protein±protein contacts either with another
of residues throughout the C terminus of EAAT1, offeringdomain in the carrier or with a separate protein, or are
additional insight into the domain structure of this regionintracellular. In the few cases in which regions of the
and resolving some of the more controversial aspectstransporter were devoid of accessible cysteine substitu-
of carrier topology. Such information is essential fortions, we relied on a combination of our data and infor-
the interpretation of many aspects of its structure andmation from other studies, together with data on hydro-
phobicity and conservation, to propose their membrane function.
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Experimental Procedures were placed on ice and then lysed in buffer containing 150 mM
NaCl, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, 0.02%
NaN3, Complete protease inhibitor cocktail tablets (EDTA-free)Construction of Site-Directed Mutants
Single cysteine substitution mutants were created using a PCR- (Roche), and 50 mM Tris±Cl (pH 8.0). After 30 min on a rotating
shaker, lysates were transferred to microcentrifuge tubes and spunbased mutagenesis strategy, as previously described (Seal and
Amara, 1998). Each mutant PCR product was subcloned into Cys(2), for 15 min at 15,000 3 g at 48C to remove the insoluble material.
The supernatant was transferred to a new tube and the volumewhich was in the pCMV5 vector for expression in COS7 cells, and
then sequenced by Dye Terminator Cycle Sequencing (ABI PRISM, brought up to 1 ml with immunoprecipitation (IP) buffer containing
150 mM NaCl, 0.1% NP-40, 1 mM EDTA, 0.25% gelatin, 0.02% NaN3,Perkin Elmer).
and 50 mM Tris±HCl (pH 7.5). The IP was carried out at 48C with
the C-terminal antibody to EAAT1 (1:5,000 dilution) for 1 hr withFunctional Characterization of the Cysteine
mixing, and then protein A-Sepharose (Sigma, St Louis, MO) wasSubstitution Carriers
added for an additional hr. Sepharose beads were washed twiceThe ability to mediate the accumulation of L-glutamate was deter-
for 20 min at 48C on a nutator, twice with IP buffer, and once withmined for each cysteine substitution mutant in COS7 cells. Cells
a buffer containing 0.1% NP-40 and 10 mM Tris±HCl (pH 7.5). Afterwere transiently transfected using the DEAE-dextran method, and
aspirating off all wash buffer, 23 SDS sample buffer was added,48 hr later a radiolabeled L-glutamate transport assay was per-
and samples were heated to 1008C for 3 min and then separatedformed (Arriza et al., 1994). Cells were incubated for 10 min at room
on 8% polyacrylamide gels under denaturing conditions. Proteinstemperature with 1 mM L-glutamate (999.9 mM nonlabeled L-gluta-
were transferred to Immobilon-P (Millipore, Bedford, MA) for West-mate 1 0.1 mM [3H]L-glutamate [24 Ci/mmol]), washed twice with
ern blotting. After blocking with 2% bovine serum albumin (Sigma),ice-cold phosphate-buffered saline (PBS), solubilized in 0.1% SDS,
blots were incubated with a 1:10,000 dilution of strepavidin-HRPand counted in a Beckman scintillation counter. Velocity values for
(Pierce, Rockford, IL) and then developed by chemiluminescenceeach mutant are expressed as a percent of the maximum velocity
(Dupont NEN, Boston, MA). Strepavidin-HRP also detects the EAAT1observed with Cys(2).
antibody IgGs. Blots were reprobed with the C-terminal EAAT1 anti-
body (1:5,000) and then visualized with an HRP-conjugated anti-Labeling of Cysteine Mutants with MTS Derivatives
rabbit secondary antibody (1:10,000; Amersham, Arlington Heights,Labeling and detection of the cysteine substitutions were carried
IL) and chemiluminescence (Dupont NEN, Boston, MA).out essentially as described previously (Seal et al., 1998). COS7
cells were distributed into 6-well plates and the next day transiently
Application of MTS Derivatives and Measurementtransfected with the transporter mutants using the DEAE-dextran
of the Transport Activitymethod; 48 hr later, the transfected cells were washed twice with
COS7 cells were transiently transfected by the DEAE-dextranPBS and then incubated in the presence and absence of 1 mM
method and then assayed 2 days later. Cells were washed onceMTSET and 10 mM MTSES (Toronto Research Chemicals, North
with PBS before the MTS derivatives were added at their final con-York, Ontario, Canada) for 5 min at room temperature. Compounds
centrations of 10 mM (MTSES) and 1 mM (MTSET) for 5 min at roomwere solubilized in water as concentrated stocks immediately prior
temperature. The MTS derivatives were solubilized immediatelyto use. Cells were washed three times with PBS and incubated
prior to use. Following the incubation, cells were washed three timesfor 30 min at room temperature with 2 mM MTSEA-biotin (Toronto
with PBS and assayed for uptake of 10 mM radiolabeled L-glutamateResearch Chemicals). MTSEA-biotin was solubilized in dimethyl
(9.9 mM nonlabeled L-glutamate and 0.1 mM [3H]L-glutamate [24sulfoxide (final concentration ,1%) prior to dilution in PBS. Cells
Ci/mmol]) for 10 min at room temperature. The effect of the MTSwere washed three times with PBS and then lysed with 1 ml of lysis
derivatives on uptake is expressed as the percent inhibition of up-buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl, 5 mM EDTA,
take (PI), which was calculated as PI 5 100 2 (100 * uptake after/1% Triton X-100, and Complete protease inhibitor cocktail tablets
uptake before).(EDTA-free) (Roche). Lysates were transferred to microcentrifuge
tubes, placed on ice for z1 hr, and then spun at 14,000 3 g to pellet
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